Experiences of Brief Admission From the Perspective of Family and Significant Others

Suicidal Ideation Clinical Trial

Official title:

Experiences Among Family Members, Carers and Significant Others of Brief Admission by Self-referral for Self-harming and Suicidal Persons: a Qualitative Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04962217
• Other study ID #: 2019-02557
• Status: Completed
• Start date: June 1, 2021
• Est. completion date: December 31, 2023

Study information

• Verified date: January 2024
• Source: Region Skane
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

As a result of a randomized controlled trial (NCT02985047) BA is continuously offered to persons with self-harm at risk for suicide in Skåne, Sweden. This qualitative inductive study aims to provide experiences among family members, carers and significant others of Brief Admission by self-referral for self-harming and suicidal persons based on individual semi-structured interviews. Participants will be identified through suggestion from persons with an active BA contract. Interviews, estimated to last 30-60 minutes, will be analyzed by a phenomenological hermeneutic method or by content analysis depending on richness and depth in the interviews. Findings from this study will be published.

Description:

As a result of the randomized controlled trial evaluating BA in Skåne (NCT02985047), BA is since January 2019, continuously offered to persons with self-harm at risk for suicide in Skåne, Sweden. Parallel to the clinical trial qualitative interview studies have been performed on the experiences of BA, with participants during the pilot phase of the trial and among the most severely ill persons and from the viewpoint of psychiatric staff. The present study aims to complement the above-mentioned studies with analysis of real-life experiences of BA from the perspective of loved ones to persons with current access to BA. This is important since the persons close to those suffering from recurrent self-harm and suicidal ideation play an essential role in times of crisis and may beneficially contribute to motivation as well as effects of provided care.

In this qualitative inductive study individual semi-structured interviews will be held with family members, carers and significant others of persons with an active BA contract, who has given informed consent to participate. To identify potential informants, persons with an active BA contract, who have used BA within the last three months, at the wards in Lund, Malmö, Helsingborg or Kristianstad will be contacted and asked about contact information (name and telephone number) to a person close to them who may be contacted regarding inclusion in the present study. A variation of contract length (minimum one month since first signed contract) is strived for. The number of interviews will depend on the number of active contracts at the included wards and the proportion of those where potential participants may be contacted and who subsequently consent to participate, but with a maximum of 25 interviews. Interviews are estimated to be 30-60 minutes, and will be conducted in a calm place, chosen by the participant. Interviews will be performed by doctoral students in psychiatry and supervised by a senior researcher with experience of psychiatry and qualitative research. Interviews will be transcribed and analyzed by a phenomenological hermeneutic method or by content analysis depending on richness and depth in the interviews. Findings from this study will be published.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 14
• Est. completion date: December 31, 2023
• Est. primary completion date: December 31, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria:

• Family member, carer or significant other as defined by persons with access to Brief Admission by self-referral through one of the psychiatric departments in Skåne, Sweden (Lund, Malmö, Helsingborg or Kristianstad).

• At least 18 years of age.

• Able to consent to study participation through written and oral information.

• Given consent to participate

Exclusion Criteria:

• below the age of 18.

Related Conditions & MeSH terms

• Self Injurious Behavior Without Suicidal Intent
• Self-Harm, Deliberate
• Self-Injurious Behavior
• Suicidal Ideation

Intervention

Other:
• Semi-structured interviews
Each participant will attend a 30-60 minute semi-structured interview conducted by the CI

Locations

Country	Name	City	State
Sweden	Psykiatri och habilitering, Region Skåne	Lund	Skåne

Sponsors (2)

Lead Sponsor	Collaborator
Region Skane	Lund University

Country where clinical trial is conducted

Sweden, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Lived experiences	Data from semi-structured interviews	60 minutes